STAT — A decade of reporting from the frontiers of health and medicine
An authoritative database of FDA’s fast-tracked medical devices. STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.
STAT+ Subscription | STAT
Our price covers the cost of daily coverage, two daily STAT+ newsletters, free access to exclusive subscriber only virtual events, discounts to STAT events and summits, and additional benefits.
STAT Reports
STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery from the places that matter to our readers — research labs, hospitals, executive …
STAT Madness 2026: A look at the teams vying for the coveted title
6 days ago · STAT Madness is an annual bracket-style competition in which readers vote on the most important and impactful biomedical and health research of the year.
Prasad overruled FDA staff to reject Moderna flu vaccine application
Feb 11, 2026 · WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept Moderna’s application for a new influenza vaccine, …
Who does TrumpRx actually benefit? - STAT
Feb 5, 2026 · The real winners from TrumpRx are pharmaceutical manufacturers.
TrumpRx promises cheapest drugs. Many cost less already | STAT
Feb 6, 2026 · STAT’s reporters analyzed more than 140 dosages and formulations of prescription drugs available on TrumpRx and other sites to determine where prices are cheapest.
Marty Makary addresses staff concerns over drug voucher program
Feb 3, 2026 · It has come under fire both internally and externally for allowing political officials to interfere with the drug review process, STAT previously reported.
FDA refuses to review Moderna's flu vaccine application | STAT
Feb 10, 2026 · FDA refuses to review Moderna’s influenza vaccine, which could raise concerns about the agency’s posture toward vaccines and drug approvals more generally.
Vertex's CRISPR sickle cell treatment faces a costly bottleneck | STAT
Feb 5, 2026 · Specialists at four sickle centers told STAT they’ve been surprised by one of the key stumbling blocks to faster rollout: They can’t collect enough cells to create the treatment.